학술논문
Results of a phase II randomized controlled clinical trial comparing efficacy of Cabazitaxel versus Docetaxel as second line or above therapy in recurrent head and neck cancer
Document Type
Article
Author
Source
In Oral Oncology December 2017 75:54-60
Subject
Language
ISSN
1368-8375